Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mace

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Placenta|July 11, 2003
Marginal transfer of ReoPro (Abciximab) compared with immunoglobulin G (F105), inulin and water in the perfused human placenta in vitroR K Miller, K Mace, B Polliotti, et al.
The British Journal of Dermatology|January 1, 1995
Constitutive and inducible expression of drug metabolizing enzymes in cultured human keratinocytesF Vecchini, K Mace, J Magdalou, et al.
Journal of Chemical Theory and Computation|November 13, 2018
Evaluating Charge Equilibration Methods To Generate Electrostatic Fields in Nanoporous MaterialsDaniele Ongari, Peter G Boyd, Ozge Kadioglu, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Plasma pharmacokinetics and biological activity of a human immunodeficiency virus type 1 neutralizing human monoclonal antibody, F105, in cynomolgus monkeysL A Cavacini, J Power, C L Emes, et al.
Cancer Research|June 1, 1987
Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activityK Hori, M J Ehrke, K Mace, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|January 1, 2016
Shielding concepts for low-background proportional counter arrays in surface laboratoriesC E Aalseth, P H Humble, E K Mace, et al.
Diabetes, Obesity & Metabolism|February 6, 2016
Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutideZ Milicevic, G Anglin, K Harper, et al.
Journal of Environmental Radioactivity|December 28, 2020
Background concentrations of Argon-39 in shallow soil gasB G Fritz, T R Alexander, C M Johnson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1991
Enhanced resistance to HIV-1 replication in U937 cells stably transfected with the human IFN-beta gene behind an MHC promoter fragmentK Mace, I Seif, C Anjard, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 28, 2007
Exenatide effects on statin pharmacokinetics and lipid responseP A Kothare, H Linnebjerg, Z Skrivanek, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Placenta|July 11, 2003
Marginal transfer of ReoPro (Abciximab) compared with immunoglobulin G (F105), inulin and water in the perfused human placenta in vitroR K Miller, K Mace, B Polliotti, et al.
The British Journal of Dermatology|January 1, 1995
Constitutive and inducible expression of drug metabolizing enzymes in cultured human keratinocytesF Vecchini, K Mace, J Magdalou, et al.
Journal of Chemical Theory and Computation|November 13, 2018
Evaluating Charge Equilibration Methods To Generate Electrostatic Fields in Nanoporous MaterialsDaniele Ongari, Peter G Boyd, Ozge Kadioglu, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Plasma pharmacokinetics and biological activity of a human immunodeficiency virus type 1 neutralizing human monoclonal antibody, F105, in cynomolgus monkeysL A Cavacini, J Power, C L Emes, et al.
Cancer Research|June 1, 1987
Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activityK Hori, M J Ehrke, K Mace, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|January 1, 2016
Shielding concepts for low-background proportional counter arrays in surface laboratoriesC E Aalseth, P H Humble, E K Mace, et al.
Diabetes, Obesity & Metabolism|February 6, 2016
Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutideZ Milicevic, G Anglin, K Harper, et al.
Journal of Environmental Radioactivity|December 28, 2020
Background concentrations of Argon-39 in shallow soil gasB G Fritz, T R Alexander, C M Johnson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1991
Enhanced resistance to HIV-1 replication in U937 cells stably transfected with the human IFN-beta gene behind an MHC promoter fragmentK Mace, I Seif, C Anjard, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 28, 2007
Exenatide effects on statin pharmacokinetics and lipid responseP A Kothare, H Linnebjerg, Z Skrivanek, et al.
Pageof 4